Swinburne researcher funded to help reduce the impact of drug-affected driving
![Dr Amie Hayley in her home office](/content/dam/media/staff/staff/Amie-Hayley-landscape.jpg)
Dr Amie Hayley’s work has shown that amphetamine-intoxicated drivers are more likely to die in road trauma than sober drivers.
In summary
- Senior Research Fellow at the Centre for Human Psychopharmacology, Dr Amie Hayley, has been awarded a four-year Al and Val Rosenstrauss Fellowship
- Dr Hayley will investigate how long-term use of methamphetamines affects driving to optimise the development of technologies designed to monitor driver state in real time
Senior Research Fellow at Swinburne's Centre for Human Psychopharmacology, Dr Amie Hayley, has been awarded a four-year Al and Val Rosenstrauss Fellowship to further her research into how chronic methamphetamine use affects driving skills and performance.
Dr Hayley will investigate how long-term use of methamphetamines affects driving to optimise the development of technologies designed to detect and monitor driver state in real time.
This work will advance understanding of how ocular-based technologies can be used to detect and monitor driver impairment during different phases of methamphetamine use. It will also directly contribute to the co-development of novel driver-state monitoring systems to detect methamphetamine-affected drivers in real time.
Dr Hayley’s work examines the neural, biological and clinical factors that underlie harm associated with psychoactive substance usage and aims to identify mechanisms by which these changes translate to dangerous human behaviour.
Through her experimental work at Swinburne’s Drugs and Driving Research Unit, Dr Hayley has developed a framework to support the use of ocular metrics to index driving impairment when someone is acutely intoxicated by methamphetamine.
“Driving a car is a complex task that requires a driver to be attentive, competent and capable,” Dr Hayley says.
“Despite national initiatives in Australia to reduce the impact of drug-impaired driving – such as roadside drug testing – amphetamine is now the most commonly detected illicit drug among drivers who are injured or killed due to road trauma.”
“This fellowship will allow me to develop the capabilities of vehicle-based and wearable eye-monitoring technologies to help reduce the burden of drug-affected driving.”
Dr Hayley has quantified the scope and impact of dangerous driving practices associated with methamphetamine use and identified eye-tracking technology as a novel means to monitor and index driver impairment when someone is acutely impaired by methamphetamine. She hopes to further develop impairment standards for other common drugs, thereby helping to reduce the global impact of road trauma due to psychoactive substance usage.
Dr Hayley was also awarded the 2020 Vice-Chancellor’s Research Excellence Award (Early Career).
Al and Val Rosenstrauss Fellowship
This prestigious award is named in honour of the late Al Rosenstrauss OAM and his wife, Val, for their contribution to the work of The Rebecca L Cooper Medical Research Foundation over more than 28 years. The fellowship is targeted at rising stars who are between three and 10 years post-doctoral and who are building credentials for a long and successful career in research. Fellowship recipients receive $100,000 per year for four years.
-
Media Enquiries
Related articles
-
- Technology
- Health
New MedTechVic prototypes to transform everyday lives of people with a disability
Swinburne’s MedTechVic has revealed three new prototypes designed through the joint Health-led Manufacturing Innovation Program, in partnership with the Australian Medtech Manufacturing Centre and Safer Care Victoria
Friday 19 July 2024 -
- Health
- Education
Dissociation is a common trauma response among many who seek therapy, but only one in five psychologists can accurately identify symptoms
New Swinburne research has found that four in five Australian psychologists have gaps in their knowledge on dissociation and cannot accurately identify dissociation symptoms.
Friday 21 June 2024 -
- Health
- Technology
Clinical Innovation Fellowships develop creative solutions to Australia’s healthcare challenges
MedTechVic is gearing up to begin its fourth year of the Clinical Innovation Fellowship Program (CIFP), following the highly successful third round in 2023.
Wednesday 19 June 2024 -
- Social Affairs
- Health
Swinburne leads world-first medical cannabis driving trial
Swinburne researchers are spearheading a world-first trial to evaluate whether patients can drive safely while on prescribed medical cannabis
Tuesday 28 May 2024 -
- Technology
- Health
MChart redefines mental health service planning through cutting-edge data analytics
MChart, a new tool under development by Swinburne University of Technology and University of Canberra researchers, is set to help health care providers navigate the complexities of mental health service planning using data analytics and geospatial mapping.
Monday 13 May 2024